Axogen, Inc. AXGN
50.83 USD -0.06 (-0.12%)
Nov 11, 2026, 9:37 AM EST
50.62 Day range 51.07
23.00 52-week range 52.91
- YTD
- +55.30%
- 1 year
- +107.81%
News
seekingalpha.com Axogen, Inc. (AXGN) Discusses Prostate Nerve Reconstruction Market Development Transcript Axogen, Inc. (AXGN) Discusses Prostate Nerve Reconstruction Market Development Transcript
benzinga.com Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $60 Canaccord Genuity analyst Caitlin Roberts maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $55 to $60.
benzinga.com Leerink Partners Maintains Outperform on Axogen, Raises Price Target to $56 Leerink Partners analyst Mike Kratky maintains Axogen (NASDAQ:AXGN) with a Outperform and raises the price target from $52 to $56.
benzinga.com Barclays Maintains Overweight on Axogen, Raises Price Target to $60 Barclays analyst Christopher Pasquale maintains Axogen (NASDAQ:AXGN) with a Overweight and raises the price target from $50 to $60.
benzinga.com Truist Securities Maintains Buy on Axogen, Raises Price Target to $60 Truist Securities analyst Ravi Misra maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $53 to $60.
benzinga.com Wells Fargo Maintains Overweight on Axogen, Raises Price Target to $56 Wells Fargo analyst Larry Biegelsen maintains Axogen (NASDAQ:AXGN) with a Overweight and raises the price target from $48 to $56.
benzinga.com Microsoft To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Thursday Analysts raised targets for Microsoft, VF, Glaukos, Hilton, AxoGen and Brinker; Renasant’s target was cut and its rating downgraded.
benzinga.com HC Wainwright & Co. Maintains Buy on Axogen, Raises Price Target to $56 HC Wainwright & Co. analyst Yi Chen maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $53 to $56.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Pulmonx (NASDAQ:LUNG) stock increased by 33.1% to $2.63 during Wednesday's regular session. The company's market cap stands at $85.0 million. As per the press release, Q3 earnings came out…
benzinga.com Crude Oil Surges Over 3%; Brinker Posts Upbeat Earnings U.S. stocks were mixed; Dow and S&P 500 rose while Nasdaq slipped. Brinker beat estimates and raised guidance; oil jumped 3.4%.
benzinga.com Vertiv, Evercore, Brinker, GE HealthCare And Other Big Stocks Moving Higher On Wednesday U.S. stocks mixed; Dow gained ~100 points. Vertiv jumped 13.3% on strong results and raised guidance; Ultralife soared 145.8% on buyout news.
benzinga.com Axogen Q3 2026 Earnings Call Transcript Axogen (NASDAQ:AXGN) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Axogen (NASDAQ:AXGN) stock rose 17.7% to $44.1 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.1 billion. As per the news, the Q3 earnings report…- benzinga.com Axogen Q3 Adj. EPS $0.21 Beats $0.14 Estimate, Sales $75.834M Beat $73.199M Estimate Axogen (NASDAQ:AXGN) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.14 by 50 percent. This is a 75 percent increase over earnings of $0.12 per share…
- benzinga.com Barclays Maintains Overweight on Axogen, Lowers Price Target to $50 Barclays analyst Christopher Pasquale maintains Axogen (NASDAQ:AXGN) with a Overweight and lowers the price target from $55 to $50.
benzinga.com This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday Analysts initiated coverage on ASBH, QNRX, AXGN and HOOD with bullish ratings and targets; IDXX received a Sector Weight rating.
benzinga.com B of A Securities Initiates Coverage On Axogen with Buy Rating, Announces Price Target of $52 B of A Securities analyst Travis Steed initiates coverage on Axogen (NASDAQ:AXGN) with a Buy rating and announces Price Target of $52.- benzinga.com Truist Securities Maintains Buy on Axogen, Lowers Price Target to $53 Truist Securities analyst Ravi Misra maintains Axogen (NASDAQ:AXGN) with a Buy and lowers the price target from $60 to $53.
benzinga.com AMD To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Friday Analysts cut targets for GWW, IE and COST, while raising targets for OKTA, AXGN, ZS and DRI; ratings remained unchanged.- benzinga.com Raymond James Maintains Outperform on Axogen, Raises Price Target to $53 Raymond James analyst Jayson Bedford maintains Axogen (NASDAQ:AXGN) with a Outperform and raises the price target from $48 to $53.
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repair Axogen is acquiring BioCircuit Technologies for $200 million to add sutureless NerveTape to its portfolio, funded by a public stock offering.- benzinga.com Axogen Prices $208.7M Underwritten Public Offering Of 4.91M Shares At $42.50 Per Share Axogen, Inc. ("Axogen" or the "Company") (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced the
- benzinga.com Axogen To Acquire NerveTape Maker BioCircuit Technologies For $200M In Cash; Sees Deal As Accretive To FY27 Gross And Adjusted EBITDA Margins At closing, $1.0 million of the estimated merger consideration will be withheld pending determination of the post-closing purchase price adjustment. The transaction is expected to close in the fourth…
- benzinga.com Truist Securities Initiates Coverage On Axogen with Buy Rating, Announces Price Target of $60 Truist Securities analyst Ravi Misra initiates coverage on Axogen (NASDAQ:AXGN) with a Buy rating and announces Price Target of $60.
benzinga.com CommVault, Kforce, AxoGen And Other Big Stocks Moving Higher On Tuesday U.S. stocks mixed, Nasdaq down 200 points. CommVault shares up 9.9% after beating earnings estimates. Other gainers include Kforce, Omnicell, and AxoGen.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
benzinga.com Earnings Scheduled For April 28, 2026 - benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com Earnings Scheduled For February 24, 2026
benzinga.com This Tempus AI Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday 
benzinga.com Axogen Prices Upsized $124 Million Stock Offering Axogen stock fell Thursday with a session volume of 1.92 million, priced its upsized underwritten public offering at $31.00 per share.- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday 
benzinga.com Earnings Scheduled For October 29, 2025 
benzinga.com Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday - benzinga.com Earnings Scheduled For August 5, 2025
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session - benzinga.com Earnings Scheduled For May 8, 2025
- benzinga.com Earnings Scheduled For February 25, 2025
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session - benzinga.com Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.
- benzinga.com Earnings Scheduled For March 5, 2024 Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
- benzinga.com Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session Shares of Applied Therapeutics, Inc.
- benzinga.com Greenbrier Posts Upbeat Earnings, Joins Kura Sushi USA, AxoGen And Other Big Stocks Moving Higher On Friday U.S. stocks traded higher, with the Dow Jones index gaining more than 100 points on Friday. Shares of The Greenbrier Companies, Inc. (NYSE: GBX) rose sharply during Friday’s session following upbeat…
- benzinga.com Earnings Scheduled For November 7, 2023 Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday During the session on Thursday, 461 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday Friday's session saw 169 companies set new 52-week lows.